178 related articles for article (PubMed ID: 10447328)
1. Interference of the antimicrobial peptide lactoferricin B with the action of various antibiotics against Escherichia coli and Staphylococcus aureus.
Vorland LH; Osbakk SA; Perstølen T; Ulvatne H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1999; 31(2):173-7. PubMed ID: 10447328
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial effects of lactoferricin B.
Vorland LH; Ulvatne H; Andersen J; Haukland HH; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1999; 31(2):179-84. PubMed ID: 10447329
[TBL] [Abstract][Full Text] [Related]
3. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin.
Vorland LH; Ulvatne H; Andersen J; Haukland H; Rekdal O; Svendsen JS; Gutteberg TJ
Scand J Infect Dis; 1998; 30(5):513-7. PubMed ID: 10066056
[TBL] [Abstract][Full Text] [Related]
4. Post-antibiotic effect of the antimicrobial peptide lactoferricin on Escherichia coli and Staphylococcus aureus.
Haukland HH; Vorland LH
J Antimicrob Chemother; 2001 Oct; 48(4):569-71. PubMed ID: 11581240
[TBL] [Abstract][Full Text] [Related]
5. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli.
Ulvatne H; Vorland LH
Scand J Infect Dis; 2001; 33(7):507-11. PubMed ID: 11515760
[TBL] [Abstract][Full Text] [Related]
6. Ultrastructural and cytochemical study of cell wall modification by lactoferrin, lactoferricin and penicillin G against Staphylococcus aureus.
Diarra MS; Lacasse P; Deschênes E; Grondin G; Paradis-Bleau C; Petitclerc D
J Electron Microsc (Tokyo); 2003; 52(2):207-15. PubMed ID: 12868591
[TBL] [Abstract][Full Text] [Related]
7. Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B.
Ulvatne H; Haukland HH; Samuelsen Ø; Krämer M; Vorland LH
J Antimicrob Chemother; 2002 Oct; 50(4):461-7. PubMed ID: 12356789
[TBL] [Abstract][Full Text] [Related]
8. Bactericidal effect of bovine lactoferrin, LFcin, LFampin and LFchimera on antibiotic-resistant Staphylococcus aureus and Escherichia coli.
Flores-Villaseñor H; Canizalez-Román A; Reyes-Lopez M; Nazmi K; de la Garza M; Zazueta-Beltrán J; León-Sicairos N; Bolscher JG
Biometals; 2010 Jun; 23(3):569-78. PubMed ID: 20195887
[TBL] [Abstract][Full Text] [Related]
9. Initial binding sites of antimicrobial peptides in Staphylococcus aureus and Escherichia coli.
Vorland LH; Ulvatne H; Rekdal O; Svendsen JS
Scand J Infect Dis; 1999; 31(5):467-73. PubMed ID: 10576125
[TBL] [Abstract][Full Text] [Related]
10. Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus.
Samuelsen O; Haukland HH; Jenssen H; Krämer M; Sandvik K; Ulvatne H; Vorland LH
FEBS Lett; 2005 Jun; 579(16):3421-6. PubMed ID: 15946666
[TBL] [Abstract][Full Text] [Related]
11. Antibacterial activity in bovine lactoferrin-derived peptides.
Hoek KS; Milne JM; Grieve PA; Dionysius DA; Smith R
Antimicrob Agents Chemother; 1997 Jan; 41(1):54-9. PubMed ID: 8980754
[TBL] [Abstract][Full Text] [Related]
12. The antimicrobial peptides lactoferricin B and magainin 2 cross over the bacterial cytoplasmic membrane and reside in the cytoplasm.
Haukland HH; Ulvatne H; Sandvik K; Vorland LH
FEBS Lett; 2001 Nov; 508(3):389-93. PubMed ID: 11728458
[TBL] [Abstract][Full Text] [Related]
13. Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time.
McDonald PJ; Craig WA; Kunin CM
J Infect Dis; 1977 Feb; 135(2):217-23. PubMed ID: 839090
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of a 2-arylsulphonylated tryptophan: the antibacterial activity of bovine lactoferricin peptides containing Trp(2-Pmc).
Haug BE; Andersen J; Rekdal O; Svendsen JS
J Pept Sci; 2002 Jul; 8(7):307-13. PubMed ID: 12148780
[TBL] [Abstract][Full Text] [Related]
15. Effect of lactoferrin in combination with penicillin on the morphology and the physiology of Staphylococcus aureus isolated from bovine mastitis.
Diarra MS; Petitclerc D; Lacasse P
J Dairy Sci; 2002 May; 85(5):1141-9. PubMed ID: 12086049
[TBL] [Abstract][Full Text] [Related]
16. Synthetic porcine lactoferricin with a 20-residue peptide exhibits antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Candida albicans.
Chen HL; Yen CC; Lu CY; Yu CH; Chen CM
J Agric Food Chem; 2006 May; 54(9):3277-82. PubMed ID: 16637685
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effects of Thiosemicarbazides with Clinical Drugs against
Chudzik-Rząd B; Malm A; Trotsko N; Wujec M; Plech T; Paneth A
Molecules; 2020 May; 25(10):. PubMed ID: 32422899
[TBL] [Abstract][Full Text] [Related]
18. Lactoferrin: an iron-binding antimicrobial protein against Escherichia coli infection.
Yen CC; Shen CJ; Hsu WH; Chang YH; Lin HT; Chen HL; Chen CM
Biometals; 2011 Aug; 24(4):585-94. PubMed ID: 21327478
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of short hydrophobic and basic-rich peptides.
Chen PW; Shyu CL; Mao FC
Am J Vet Res; 2003 Sep; 64(9):1088-92. PubMed ID: 13677384
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
Laxer RM; Mackay E; Marks MI
Chemotherapy; 1975; 21(2):90-8. PubMed ID: 168040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
